New pill shows promise for weight and diabetes in early trial
NCT ID NCT05814107
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This early-stage study tested a new drug called CT-996 in 94 overweight or obese adults, including some with type 2 diabetes. The main goal was to check safety and how the drug moves through the body. Researchers also looked at how it affects weight and blood sugar, but this is just a first step to see if the drug is safe enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Avant Santé Research Center S.A. de C.V.
San Pedro Garza García, 66260, Mexico
-
Nucleus Network Pty Ltd.
Melbourne, 3004, Australia
Conditions
Explore the condition pages connected to this study.